Other Species / Isoforms
  Kv4.2 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T38-p
PRQERKRtQDALIVL
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • PKACA (mouse)
Putative in vivo kinases:
  • PKACA (mouse)
Treatment
  • colforsin
Kv4.2 (human) PRQERKRTQDALIVL T38
Kv4.2 (mouse) PRQERKRtQDALIVL T38-p
Kv4.2 (rat) PRQERKRTQDALIVL T38
Y134
EIIGDCCYEEYKDRR
0 1
Kv4.2 (human) EIIGDCCyEEYKDRR Y134-p
Kv4.2 (mouse) EIIGDCCYEEYKDRR Y134
Kv4.2 (rat) EIIGDCCYEEYKDRR Y134
T154-p
RLQDDADtDNTGESA
0 2
Kv4.2 (human) RLQDDADTDTAGEsA T154
Kv4.2 (mouse) RLQDDADtDNTGESA T154-p
Kv4.2 (rat) RLQDDADTDNTGESA T154
S160
DtDNTGESALPTMTA
0 1
Kv4.2 (human) DTDTAGEsALPTMTA S160-p
Kv4.2 (mouse) DtDNTGESALPTMTA S160
Kv4.2 (rat) DTDNTGESALPTMTA S160
S260
SRYRFVRSVMSIIDV
0 1
Kv4.2 (human) SRYRFVRsVMSIIDV S260-p
Kv4.2 (mouse) SRYRFVRSVMSIIDV S260
Kv4.2 (rat) SRYRFVRSVMSIIDV S260
K437-sm
LARIRAAkSGSANAY
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
Kv4.2 (human) LARIRAAksGsANAy K437-sm
Kv4.2 (mouse) LARIRAAkSGSANAY K437-sm
Kv4.2 (rat) LARIRAAksGSANAY K437-sm
S438
ARIRAAkSGSANAYM
4 1
Kv4.2 (human) ARIRAAksGsANAyM S438-p
Kv4.2 (mouse) ARIRAAkSGSANAYM S438
Kv4.2 (rat) ARIRAAksGSANAYM S438-p
S440
IRAAkSGSANAYMQS
0 1
Kv4.2 (human) IRAAksGsANAyMQs S440-p
Kv4.2 (mouse) IRAAkSGSANAYMQS S440
Kv4.2 (rat) IRAAksGSANAYMQs S440
Y444
kSGSANAYMQSKRNG
0 1
Kv4.2 (human) ksGsANAyMQsKRNG Y444-p
Kv4.2 (mouse) kSGSANAYMQSKRNG Y444
Kv4.2 (rat) ksGSANAYMQsKRNG Y444
S447
SANAYMQSKRNGLLS
1 1
Kv4.2 (human) sANAyMQsKRNGLLS S447-p
Kv4.2 (mouse) SANAYMQSKRNGLLS S447
Kv4.2 (rat) SANAYMQsKRNGLLS S447-p
S459
LLSNQLQSSEDEPAF
1 0
Kv4.2 (human) LLSNQLQSSEDEQAF S459
Kv4.2 (mouse) LLSNQLQSSEDEPAF S459
Kv4.2 (rat) LLSNQLQsSEDEPAF S459-p
S473-p
FISKSGSsFETQHHH
0 1
Kv4.2 (human) FVSKSGSSFETQHHH S473
Kv4.2 (mouse) FISKSGSsFETQHHH S473-p
Kv4.2 (rat) FVSKSGSSFETQHHH S473
S520-p
SSHSPSLssQQGVTS
0 1
Kv4.2 (human) SSHSPSLSSQQGVTS S520
Kv4.2 (mouse) SSHSPSLssQQGVTS S520-p
Kv4.2 (rat) SSHSPSLSSQQGVTS S520
S521-p
SHSPSLssQQGVTST
0 1
Kv4.2 (human) SHSPSLSSQQGVTST S521
Kv4.2 (mouse) SHSPSLssQQGVTST S521-p
Kv4.2 (rat) SHSPSLSSQQGVTST S521
T537
CSRRHKKTFRIPNAN
1 1
Kv4.2 (human) CSRRHKKtFRIPNAN T537-p
Kv4.2 (mouse) CSRRHKKTFRIPNAN T537
Kv4.2 (rat) CSRRHKKsFRIPNAN S537-p
S546-p
RIPNANVsGsHRGsV
0 3
Kv4.2 (human) RIPNANVSGSHQGsI S546
Kv4.2 (mouse) RIPNANVsGsHRGsV S546-p
Kv4.2 (rat) RIPNANVSGsHRGsV S546
S548-p
PNANVsGsHRGsVQE
0 6
Kv4.2 (human) PNANVSGSHQGsIQE S548
Kv4.2 (mouse) PNANVsGsHRGsVQE S548-p
Kv4.2 (rat) PNANVSGsHRGsVQE S548-p
S552-p
VsGsHRGsVQELSTI
Upstream
Downstream
6 8
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • PKACA (mouse)
Putative in vivo kinases:
  • PKACA (mouse)
Treatment
  • colforsin
Kv4.2 (human) VSGSHQGsIQELSTI S552-p
Kv4.2 (mouse) VsGsHRGsVQELSTI S552-p
Kv4.2 (rat) VSGsHRGsVQELSTI S552-p
S570-p
CVERTPLsNsRssLN
0 1
Kv4.2 (human) CVERTPLSNSRSSLN S570
Kv4.2 (mouse) CVERTPLsNsRssLN S570-p
Kv4.2 (rat) CVERTPLSNsRSsLN S570
S572-p
ERTPLsNsRssLNAk
0 3
Kv4.2 (human) ERTPLSNSRSSLNAk S572
Kv4.2 (mouse) ERTPLsNsRssLNAk S572-p
Kv4.2 (rat) ERTPLSNsRSsLNAk S572-p
S574-p
TPLsNsRssLNAkME
0 3
Kv4.2 (human) TPLSNSRSSLNAkME S574
Kv4.2 (mouse) TPLsNsRssLNAkME S574-p
Kv4.2 (rat) TPLSNsRSsLNAkME S574
S575-p
PLsNsRssLNAkMEE
0 3
Kv4.2 (human) PLSNSRSSLNAkMEE S575
Kv4.2 (mouse) PLsNsRssLNAkMEE S575-p
Kv4.2 (rat) PLSNsRSsLNAkMEE S575-p
K579-sm
sRssLNAkMEECVKL
2 0
Kv4.2 (human) SRSSLNAkMEECVKL K579-sm
Kv4.2 (mouse) sRssLNAkMEECVKL K579-sm
Kv4.2 (rat) sRSsLNAkMEECVKL K579-sm
T602-p
TAIISIPtPPVttPE
Upstream
6 1
Putative in vivo kinases:
  • ERK2 (human)
Kv4.2 (human) TAIISIPTPPVTTPE T602
Kv4.2 (mouse) TAIISIPtPPVttPE T602-p
Kv4.2 (rat) TAIISIPtPPVTtPE T602-p
T606-p
SIPtPPVttPEGDDR
0 1
Kv4.2 (human) SIPTPPVTTPEGDDR T606
Kv4.2 (mouse) SIPtPPVttPEGDDR T606-p
Kv4.2 (rat) SIPtPPVTtPEGDDR T606
T607-p
IPtPPVttPEGDDRP
Upstream
Downstream
7 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • neural plasticity
Putative in vivo kinases:
  • ERK2 (human)
  • P38A (mouse)
Treatment
  • kainic_acid
  • SB203580
Kv4.2 (human) IPTPPVTTPEGDDRP T607
Kv4.2 (mouse) IPtPPVttPEGDDRP T607-p
Kv4.2 (rat) IPtPPVTtPEGDDRP T607-p
S616-p
EGDDRPEsPEYsGGN
Upstream
Downstream
8 0
Effects on Modified Protein
  • activity, induced
  • activity, inhibited
Effects on Biological Processes:
  • neural plasticity
Putative in vivo kinases:
  • ERK1 (mouse)
  • ERK2 (human)
  • ERK2 (mouse)
  • GSK3B (mouse)
Treatment
  • beta-amyloid_42
  • chronic unpredictable stress
  • CT-99021
  • GSK-3_Inhibitor_XVI
  • siRNA
  • triciribine
Kv4.2 (human) EGDDRPESPEYSGGN S616
Kv4.2 (mouse) EGDDRPEsPEYsGGN S616-p
Kv4.2 (rat) EGDDRPEsPEYSGGN S616-p
S620-p
RPEsPEYsGGNIVRV
0 1
Kv4.2 (human) RPESPEYSGGNIVRV S620
Kv4.2 (mouse) RPEsPEYsGGNIVRV S620-p
Kv4.2 (rat) RPEsPEYSGGNIVRV S620